Showing results (241-250 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|July 14, 2005
Drug use and breastfeedingKenneth F Ilett, Judith H KristensenExpert Opinion on Drug Safety|November 25, 2022
Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysisAlessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, et al.Expert Opinion on Drug Safety|December 23, 2022
Adverse events in long-term studies of exogenous melatoninFrank M C Besag, Michael J VaseyExpert Opinion on Drug Safety|January 23, 2023
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanerceptKimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, et al.Expert Opinion on Drug Safety|July 6, 2021
A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims databaseShungo Imai, Kenji Momo, Hitoshi Kashiwagi, et al.Expert Opinion on Drug Safety|July 13, 2021
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglyceridesManan Pareek, R Preston Mason, Deepak L BhattExpert Opinion on Drug Safety|July 26, 2021
Gastroenterological safety of IL-17 inhibitors: a systematic literature reviewBénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, et al.Expert Opinion on Drug Safety|July 26, 2021
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studiesAntonio Riccardo Buonomo, Giulio Viceconte, Emanuela Zappulo, et al.Expert Opinion on Drug Safety|July 14, 2021
Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting systemVijay Kumar, Anand Prakash Singh, Nicholas Wheeler, et al.Expert Opinion on Drug Safety|July 15, 2021
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccinesMaurizio Sessa, Kristian Kragholm, Anders Hviid, et al.Pageof 281